Varex Imaging (NASDAQ:VREX) Upgraded to Strong-Buy at Wall Street Zen

Wall Street Zen upgraded shares of Varex Imaging (NASDAQ:VREX) from a buy rating to a strong-buy rating in a research report released on Saturday morning.

Other analysts have also issued reports about the stock. B. Riley Financial restated a “buy” rating on shares of Varex Imaging in a research report on Thursday, February 12th. Oppenheimer decreased their price objective on Varex Imaging from $23.00 to $18.00 and set an “outperform” rating on the stock in a report on Wednesday, November 19th. Weiss Ratings restated a “sell (d-)” rating on shares of Varex Imaging in a report on Monday, December 29th. Finally, Jefferies Financial Group restated a “hold” rating and set a $14.50 price target on shares of Varex Imaging in a research report on Monday, February 2nd. Two investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $16.17.

Varex Imaging Stock Down 2.6%

Shares of VREX opened at $13.17 on Friday. Varex Imaging has a 1 year low of $6.76 and a 1 year high of $14.56. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.89 and a quick ratio of 1.87. The stock has a 50 day simple moving average of $13.30 and a two-hundred day simple moving average of $12.22. The firm has a market cap of $551.82 million, a P/E ratio of -8.03 and a beta of 0.90.

Varex Imaging (NASDAQ:VREX) last announced its quarterly earnings data on Tuesday, February 10th. The company reported $0.19 earnings per share for the quarter, topping analysts’ consensus estimates of $0.14 by $0.05. Varex Imaging had a negative net margin of 7.92% and a positive return on equity of 8.43%. The firm had revenue of $209.60 million during the quarter, compared to analyst estimates of $207.83 million. Varex Imaging has set its Q2 2026 guidance at 0.150-0.250 EPS. On average, analysts forecast that Varex Imaging will post 0.53 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Varex Imaging

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Invesco Ltd. boosted its holdings in Varex Imaging by 8.1% in the fourth quarter. Invesco Ltd. now owns 151,891 shares of the company’s stock valued at $1,770,000 after acquiring an additional 11,318 shares in the last quarter. Mackenzie Financial Corp raised its holdings in Varex Imaging by 58.2% in the 4th quarter. Mackenzie Financial Corp now owns 29,060 shares of the company’s stock worth $346,000 after purchasing an additional 10,691 shares in the last quarter. Empowered Funds LLC lifted its position in shares of Varex Imaging by 5.9% in the 4th quarter. Empowered Funds LLC now owns 230,376 shares of the company’s stock worth $2,684,000 after purchasing an additional 12,800 shares during the period. Zacks Investment Management purchased a new stake in shares of Varex Imaging in the 4th quarter worth about $398,000. Finally, Tudor Investment Corp ET AL bought a new stake in shares of Varex Imaging during the 4th quarter valued at about $863,000.

About Varex Imaging

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.